2026-09-18T21:10:17Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/761742026-06-06T01:05:50Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Philip Hilts.
Maurer, Lauren N. (Lauren Nichole)
Massachusetts Institute of Technology. Graduate Program in Science Writing.
Massachusetts Institute of Technology. Graduate Program in Science Writing
MIT Program in Writing & Humanistic Studies
2013-01-07T21:30:17Z
2013-01-07T21:30:17Z
2012
2012
http://hdl.handle.net/1721.1/76174
821883508
Thesis (S.M. in Science Writing)--Massachusetts Institute of Technology, Dept. of Humanities, Graduate Program in Science Writing, 2012.
Cataloged from PDF version of thesis.
Includes bibliographical references (p. 23-25).
In the 1960's, psychedelic drugs were a part of not only popular culture, but also cuttingedge psychology research. Scientists were studying these drugs in the hope of understanding and treating various psychological and societal ills; but as psychedelics got caught up in the counter-culture, they fell out of favor with the public, and practically vanished from the research world as quickly as they'd appeared. Now, decades after they all but disappeared, psychedelics are making a comeback. Focusing primarily on research with psychedelics to treat post-traumatic stress disorder as well as anxiety and depression associated with terminal illness, this thesis examines the researchers who've brought psychedelic medicine back from the brink and the work they're doing to explore the potential within these complex and controversial drugs.
by Lauren N. Maurer.
S.M. in Science Writing
25 p.
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by
copyright. They may be viewed from this source for any purpose, but
reproduction or distribution in any format is prohibited without written
permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Graduate Program in Science Writing.
Flashback : the return of psychedelic medicine
Return of psychedelic medicine
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="1dec7c03-8277-46bc-b532-5d3f4d623242">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Flashback : the return of psychedelic medicine</Title>
<Subtitle>Return of psychedelic medicine</Subtitle>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2012</PublicationDate>
<Authors>
<Author>
<DisplayName>Maurer, Lauren N. (Lauren Nichole)</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Graduate Program in Science Writing.</Keyword>
<Abstract>In the 1960's, psychedelic drugs were a part of not only popular culture, but also cuttingedge psychology research. Scientists were studying these drugs in the hope of understanding and treating various psychological and societal ills; but as psychedelics got caught up in the counter-culture, they fell out of favor with the public, and practically vanished from the research world as quickly as they'd appeared. Now, decades after they all but disappeared, psychedelics are making a comeback. Focusing primarily on research with psychedelics to treat post-traumatic stress disorder as well as anxiety and depression associated with terminal illness, this thesis examines the researchers who've brought psychedelic medicine back from the brink and the work they're doing to explore the potential within these complex and controversial drugs.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>